Safety of First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC: A Pooled Analysis of CheckMate 227, CheckMate 568, and CheckMate 817.
Saved in:
| Title: | Safety of First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC: A Pooled Analysis of CheckMate 227, CheckMate 568, and CheckMate 817. |
|---|---|
| Authors: | Paz-Ares LG; Medical Oncology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain. Electronic address: lpazaresr@seom.org., Ciuleanu TE; Department of Medical Oncology, Institutul Oncologic Prof. Dr. Ion Chiricuta and University of Medicine and Pharmacy Iulia Hatieganu, Cluj-Napoca, Romania., Pluzanski A; Department of Lung Cancer and Chest Tumours, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Lee JS; Department of Hematology/Oncology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Gainor JF; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts., Otterson GA; The Ohio State University-James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio., Audigier-Valette C; Orientation Oncologique, Hôpital Sainte-Musse, Toulon, France., Ready N; Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Schenker M; Department of Medical Oncology, Sf Nectarie Oncology Center, Craiova, Romania., Linardou H; Fourth Oncology Department and Comprehensive Clinical Trials Center, Metropolitan Hospital, Athens, Greece., Caro RB; Medical Oncology Department, Hospital Universitario Virgen Del Rocio, Instituto de Biomedicina de Seville, Seville, Spain., Provencio M; Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain., Zurawski B; Chemotherapy Department, Ambulatorium Chemioterapii, Bydgoszcz, Poland., Lee KH; Medical Oncology, Chungbuk National University Hospital, Cheongju-si, Republic of Korea., Kim SW; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Caserta C; Medical Oncology Department, Santa Maria Hospital, Terni, Italy., Ramalingam SS; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia., Spigel DR; Thoracic Medical Oncology, Sarah Cannon Research Institute/Tennessee Oncology PLLC, Nashville, Tennessee., Brahmer JR; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland., Reck M; Department of Thoracic Oncology, Airway Research Center North, German Center for Lung Research, LungClinic, Grosshansdorf, Germany., O'Byrne KJ; Princess Alexandra Hospital, Translational Research Institute and Queensland University of Technology, Brisbane, Queensland, Australia., Girard N; Institut du Thorax Curie-Montsouris, Institut Curie, Paris, France., Popat S; Lung Unit, Royal Marsden Hospital, London, United Kingdom; The Institute of Cancer Research, University of London, London, United Kingdom., Peters S; Oncology Department, Lausanne University Hospital, Lausanne, Switzerland., Memaj A; Global Biometrics and Data Sciences, Bristol Myers Squibb, Princeton, New Jersey., Nathan F; Medical Oncology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain; Medical Oncology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain., Aanur N; OneClinical, Bristol Myers Squibb, Princeton, New Jersey., Borghaei H; Hematology and Oncology Department, Fox Chase Cancer Center, Temple Health System, Philadelphia, Pennsylvania. |
| Source: | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2023 Jan; Vol. 18 (1), pp. 79-92. Date of Electronic Publication: 2022 Aug 30. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36049658 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety of First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC: A Pooled Analysis of CheckMate 227, CheckMate 568, and CheckMate 817. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Paz-Ares+LG%22">Paz-Ares LG</searchLink>; Medical Oncology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain. Electronic address: lpazaresr@seom.org.<br /><searchLink fieldCode="AU" term="%22Ciuleanu+TE%22">Ciuleanu TE</searchLink>; Department of Medical Oncology, Institutul Oncologic Prof. Dr. Ion Chiricuta and University of Medicine and Pharmacy Iulia Hatieganu, Cluj-Napoca, Romania.<br /><searchLink fieldCode="AU" term="%22Pluzanski+A%22">Pluzanski A</searchLink>; Department of Lung Cancer and Chest Tumours, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Lee+JS%22">Lee JS</searchLink>; Department of Hematology/Oncology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Gainor+JF%22">Gainor JF</searchLink>; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Otterson+GA%22">Otterson GA</searchLink>; The Ohio State University-James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Audigier-Valette+C%22">Audigier-Valette C</searchLink>; Orientation Oncologique, Hôpital Sainte-Musse, Toulon, France.<br /><searchLink fieldCode="AU" term="%22Ready+N%22">Ready N</searchLink>; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Schenker+M%22">Schenker M</searchLink>; Department of Medical Oncology, Sf Nectarie Oncology Center, Craiova, Romania.<br /><searchLink fieldCode="AU" term="%22Linardou+H%22">Linardou H</searchLink>; Fourth Oncology Department and Comprehensive Clinical Trials Center, Metropolitan Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Caro+RB%22">Caro RB</searchLink>; Medical Oncology Department, Hospital Universitario Virgen Del Rocio, Instituto de Biomedicina de Seville, Seville, Spain.<br /><searchLink fieldCode="AU" term="%22Provencio+M%22">Provencio M</searchLink>; Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Zurawski+B%22">Zurawski B</searchLink>; Chemotherapy Department, Ambulatorium Chemioterapii, Bydgoszcz, Poland.<br /><searchLink fieldCode="AU" term="%22Lee+KH%22">Lee KH</searchLink>; Medical Oncology, Chungbuk National University Hospital, Cheongju-si, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+SW%22">Kim SW</searchLink>; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Caserta+C%22">Caserta C</searchLink>; Medical Oncology Department, Santa Maria Hospital, Terni, Italy.<br /><searchLink fieldCode="AU" term="%22Ramalingam+SS%22">Ramalingam SS</searchLink>; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Spigel+DR%22">Spigel DR</searchLink>; Thoracic Medical Oncology, Sarah Cannon Research Institute/Tennessee Oncology PLLC, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Brahmer+JR%22">Brahmer JR</searchLink>; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland.<br /><searchLink fieldCode="AU" term="%22Reck+M%22">Reck M</searchLink>; Department of Thoracic Oncology, Airway Research Center North, German Center for Lung Research, LungClinic, Grosshansdorf, Germany.<br /><searchLink fieldCode="AU" term="%22O'Byrne+KJ%22">O'Byrne KJ</searchLink>; Princess Alexandra Hospital, Translational Research Institute and Queensland University of Technology, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Girard+N%22">Girard N</searchLink>; Institut du Thorax Curie-Montsouris, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Popat+S%22">Popat S</searchLink>; Lung Unit, Royal Marsden Hospital, London, United Kingdom; The Institute of Cancer Research, University of London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Peters+S%22">Peters S</searchLink>; Oncology Department, Lausanne University Hospital, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Memaj+A%22">Memaj A</searchLink>; Global Biometrics and Data Sciences, Bristol Myers Squibb, Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Nathan+F%22">Nathan F</searchLink>; Medical Oncology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain; Medical Oncology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Aanur+N%22">Aanur N</searchLink>; OneClinical, Bristol Myers Squibb, Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Borghaei+H%22">Borghaei H</searchLink>; Hematology and Oncology Department, Fox Chase Cancer Center, Temple Health System, Philadelphia, Pennsylvania. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101274235%22">Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer</searchLink> [J Thorac Oncol] 2023 Jan; Vol. 18 (1), pp. 79-92. <i>Date of Electronic Publication: </i>2022 Aug 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101274235 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1556-1380 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215560864%22">15560864 </searchLink><i>NLM ISO Abbreviation: </i>J Thorac Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36049658 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jtho.2022.08.014 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 79 Titles: – TitleFull: Safety of First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC: A Pooled Analysis of CheckMate 227, CheckMate 568, and CheckMate 817. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Paz-Ares LG – PersonEntity: Name: NameFull: Ciuleanu TE – PersonEntity: Name: NameFull: Pluzanski A – PersonEntity: Name: NameFull: Lee JS – PersonEntity: Name: NameFull: Gainor JF – PersonEntity: Name: NameFull: Otterson GA – PersonEntity: Name: NameFull: Audigier-Valette C – PersonEntity: Name: NameFull: Ready N – PersonEntity: Name: NameFull: Schenker M – PersonEntity: Name: NameFull: Linardou H – PersonEntity: Name: NameFull: Caro RB – PersonEntity: Name: NameFull: Provencio M – PersonEntity: Name: NameFull: Zurawski B – PersonEntity: Name: NameFull: Lee KH – PersonEntity: Name: NameFull: Kim SW – PersonEntity: Name: NameFull: Caserta C – PersonEntity: Name: NameFull: Ramalingam SS – PersonEntity: Name: NameFull: Spigel DR – PersonEntity: Name: NameFull: Brahmer JR – PersonEntity: Name: NameFull: Reck M – PersonEntity: Name: NameFull: O'Byrne KJ – PersonEntity: Name: NameFull: Girard N – PersonEntity: Name: NameFull: Popat S – PersonEntity: Name: NameFull: Peters S – PersonEntity: Name: NameFull: Memaj A – PersonEntity: Name: NameFull: Nathan F – PersonEntity: Name: NameFull: Aanur N – PersonEntity: Name: NameFull: Borghaei H IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2023 Jan Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1556-1380 Numbering: – Type: volume Value: 18 – Type: issue Value: 1 Titles: – TitleFull: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Type: main |
| ResultId | 1 |
